+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analysis of Abbott Laboratories 2021

  • PDF Icon

    Company Profile

  • 100 Pages
  • June 2021
  • Aruvian Research
  • ID: 5367444
Abbott Laboratories is a well-known pharmaceutical company that manufactures and sells generic pharmaceuticals, nutritionals, diagnostic products, and medical devices. The company is known worldwide for many renowned brands like Similac infant formula, the Ensure line of nutritional supplements, its FreeStyle diabetes care line, and its Xience drug-eluting stents. In 2017, the company acquired another renowned medical device manufacturer, St. Jude Medical.

In recent years, the company's strong financial performance, coupled with a diversified customer base, geographical diversification, and robust manufacturing capabilities, has ensured that its business keeps growing. The company has focused on building country-specific portfolios, especially developing its brands to meet the needs of patients in many emerging markets. Abbott has over 400 healthcare and pharmaceutical development projects that are active in many emerging markets.

The company's focus on molecular diagnostics has stood it in good stead during the COVID-19 pandemic. The company got emergency use authorization from the FDA to distribute nine COVID-19 rapid antigen tests. The company's BinaxNOW COVID-19 Ag Card test is one of the fastest available molecular tests for detecting the novel coronavirus.

The publisher presents Analysis of Abbott Laboratories. A complete and comprehensive analysis of Abbott Laboratories includes an overview of the industry the company operates in and the impact of the COVID-19 pandemic on the pharmaceutical industry.

Company analysis includes a history of Abbott Laboratories, a business segment analysis of the segments Abbott Laboratories operates through, a look at the organization structure of the company, its product pipeline, investment analysis, a geographical operating segments analysis, and how Abbott Laboratories has been working at the forefront during the COVID-19 pandemic are all analyzed comprehensively in this report.

The major competitors of Abbott Laboratories, namely Dr. Reddy's Laboratories Limited, Johnson & Johnson, and Novartis AG, are analyzed through a company profile, in-depth business segment analysis, a financial analysis, and SWOT analysis. An economic analysis of Abbott Laboratories is also presented through ratio analysis, profit and loss analysis, presentation of the company balance sheet, and much more.

A SWOT Framework Analysis of Abbott Laboratories completes this in-depth company analysis.

Table of Contents

A. Executive Summary
B. Looking at the Industry
B.1 Industry Definition
B.2 Brief Profile of the Industry
B.3 Impact of Covid-19 on the Pharmaceutical Industry
B.4 Industry SWOT Analysis
C. Looking at Abbott Laboratories
C.1 Company Profile
C.2 History of the Company
C.3 Abbott Laboratories and the COVID-19 Pandemic
C.4 Organizational Divisions
C.5 Profiling the Key Executives
C.6 Products & Services
D. Looking at Business
D.1 Business Segments
D.2 Investment Analysis
D.3 Product Pipeline
D.4 Geographical Segments
D.5 Company Subsidiaries
E. SWOT Framework Analysis
E.1 Strengths to Build Upon
E.2 Weaknesses to Overcome
E.3 Opportunities to Exploit
E.4 Threats to Overcome
F. Profiling the Competition
F.1 Dr. Reddy's Laboratories Limited
F.1.1 Corporate Profile
F.1.2 Business Segment Analysis
F.1.3 Financial Analysis
F.1.4 SWOT Analysis
F.2 Johnson & Johnson
F.2.1 Corporate Profile
F.2.2 Business Segment Analysis
F.2.3 Financial Analysis
F.2.4 SWOT Analysis
F.3 Novartis AG
F.3.1 Corporate Profile
F.3.2 Business Segment Analysis
F.3.3 Financial Analysis
F.3.4 SWOT Analysis
G. Financial Analysis of the Company
G.1 Current Financials
G.2 Balance Sheet
G.3 Profit & Loss Statement
G.4 Ratio Analysis
H. Abbott Laboratories: OutlookI. Glossary of Terms

Companies Mentioned

  • Abbott Laboratories
  • Dr. Reddy's Laboratories Limited
  • Johnson & Johnson
  • Novartis AG